Real-World study tests Benralizumab's impact on severe asthma control

NCT ID NCT06422078

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 300 adults with severe eosinophilic asthma who are prescribed benralizumab as part of their normal care in Germany. Researchers will track changes in asthma control, lung function, and medication use over one year. The goal is to see how the drug performs outside of controlled clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

benralizumab

What this could lead to

If successful, this study could show that benralizumab helps patients with severe asthma achieve better control and reduce their need for other medications in real-world settings.

What could go wrong

This is an observational study, not a controlled trial, so results may be influenced by factors other than the drug. It is also limited to Germany, which may not apply to other populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma inherited susceptibility to asthma pulmonary eosinophilia T2-high asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA, BRONCHIAL

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Ahrensburg, Germany
Research Site
RECRUITING

Ansbach, Germany
Research Site
RECRUITING

Aschaffenburg, Germany
Research Site
RECRUITING

Auerbach, Germany
Research Site
RECRUITING

Augsburg, Germany
Research Site
RECRUITING

Bad Homburg, Germany
Research Site
RECRUITING

Berlin, Germany
Research Site
RECRUITING

Cottbus, Germany
Research Site
RECRUITING

Darmstadt, Germany
Research Site
RECRUITING

Dresden, Germany
Research Site
RECRUITING

Düsseldorf, Germany
Research Site
RECRUITING

Ehringshausen, Germany
Research Site
RECRUITING

Erkelenz, Germany
Research Site
RECRUITING

Essen, Germany
Research Site
RECRUITING

Flensburg, Germany
Research Site
RECRUITING

Frankfurt am Main, Germany
Research Site
RECRUITING

Garmisch-Partenkirchen, Germany
Research Site
RECRUITING

Halle, Germany
Research Site
RECRUITING

Hamburg, Germany
Research Site
RECRUITING

Hanover, Germany
Research Site
WITHDRAWN

Heidelberg, Germany
Research Site
RECRUITING

Heidelberg, Germany
Research Site
RECRUITING

Hohenstein-Ernsttahl, Germany
Research Site
RECRUITING

Itzehoe, Germany
Research Site
RECRUITING

Jena, Germany
Research Site
RECRUITING

Leipzig, Germany
Research Site
RECRUITING

Loerrach, Germany
Research Site
RECRUITING

Lübeck, Germany
Research Site
RECRUITING

Lüneburg, Germany
Research Site
RECRUITING

Markkleeberg, Germany
Research Site
RECRUITING

Mönchengladbach, Germany
Research Site
RECRUITING

Neuruppin, Germany
Research Site
RECRUITING

Nuremberg, Germany
Research Site
RECRUITING

Papenburg, Germany
Research Site
RECRUITING

Rostock, Germany
Research Site
RECRUITING

Saalfeld, Germany
Research Site
RECRUITING

Spardorf, Germany
Research Site
RECRUITING

Weißenburg, Germany
Research Site
RECRUITING

Wilhelmshaven, Germany
Research Site
RECRUITING

Würzburg, Germany
Research Site
RECRUITING

Zossen, Germany